A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic

Supportive Care in Cancer

Volumn 22, Issue 7, 2014, Pages 1965-1971

  Raj, Sunil X ^a,b   Thronaes, Morten ^a,b   Brunelli, Cinzia ^a,d   Hjermstad, Marianne J ^a,c   Klepstad, Pål ^a,b   Kaasa, Stein ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breakthrough pain; Cancer; Cross sectional; Outpatients; Pain; Prevalence

Indexed keywords

ADULT; AGED; ALBERTA BREAKTHROUGH PAIN ASSESSMENT TOOL; ARTICLE; BREAKTHROUGH PAIN; BRIEF PAIN INVENTORY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; COGNITION; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULARLY TARGETED THERAPY; OUTPATIENT; OUTPATIENT DEPARTMENT; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SCREENING; TERTIARY CARE CENTER;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; BREAKTHROUGH PAIN; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NORWAY; OUTPATIENTS; PAIN MEASUREMENT; PREVALENCE; YOUNG ADULT;

EID: 84902381482     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2178-3     Document Type: Article

References (25)

1. Barbera L, Seow H, Howell D, Sutradhar R, Earle C, Liu Y, Stitt A, Husain A, Sussman J, Dudgeon D (2010) Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer 116:5767-5776
2. Cleeland CS (1989) Measurement of pain by subjective report. In: Chapman CR, Loeser JD (eds) Advances in pain research and therapy. Raven, New York, pp 391-403
3. O'Connor M, Weir J, Butcher I, Kleiboer A, Murray G, Sharma N, Thekkumpurath P, Walker J, Fallon M, Storey DJ, Sharpe M (2011) Pain in patients attending a specialist cancer service: prevalence and association with emotional distress. J Pain Symptom Manage 43(1): 29-38
4. Mercadante S, Radbruch L, Caraceni A, Cherny N, Kaasa S, Nauck F, Ripamonti C, De Conno F (2002) Episodic (breakthrough) pain: Consensus Conference of an ExpertWorking Group of the European Association for Palliative Care. Cancer 94:832-839 (Pubitemid 34132314)
5. Zeppetella G, O'Doherty CA, Collins S (2000) Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage 20:87-92
6. Portenoy RK, Hagen NA (1990) Breakthrough pain: definition, prevalence and characteristics. Pain 41:273-281 (Pubitemid 20187930)
7. Payne R (2007) Recognition and diagnosis of breakthrough pain. Pain Med 8(Suppl 1):S3-S7
8. Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA (2010) Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics. J Opioid Manag 6:97-108
9. Valeberg BT, Miaskowski C, Hanestad BR, Bjordal K, Moum T, Rustoen T (2008) Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications. Clin J Pain 24:627-636
10. Fainsinger RL, Nekolaichuk C, Lawlor P, Hagen N, Bercovitch M, Fisch M, Galloway L,KayeG, LandmanW, Spruyt O, ZhukovskyD, Bruera E, Hanson J (2010) An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 46:2896-2904
11. Knudsen AK, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M, Fainsinger R, Aass N, Fayers P, Caraceni A, Klepstad P, European Palliative Care Research Collaborative, European Pharmacogenetic Study (2011) Which variables are associated with pain intensity and treatment response in advanced cancer patients? Implications for a future classification system for cancer pain. Eur J Pain 15:320-327
12. Cleeland CS (1991) Pain assessment in cancer. CRC Press, Boca Raton
13. Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17:197-210 (Pubitemid 13012221)
14. Hagen N, Stiles C, Nekolaichuk C, Biondo P, Carlson L, Fisher K, Fainsinger R (2008) The Alberta Breakthrough Pain Assessment Tool for Cancer Patients: a validation study using a Delphi process and patient think-aloud interviews. J Pain Symptom Manage 17:136-152
15. Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS, Kaasa S (2002) The Norwegian Brief Pain Inventory Questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 24:517-525 (Pubitemid 36120427)
16. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592-596 (Pubitemid 24065792)
17. Shvartzman P, FrigerM, Shani A, Barak F, YoramC, SingerY (2003) Pain control in ambulatory cancer patients-can we do better? J Pain Symptom Manage 26:716-722 (Pubitemid 36952347)
18. Davies A, Zeppetella G, Andersen S, Damkier A, Vejlgaard T, Nauck F, Radbruch L, Sjolund KF, Stenberg M, Buchanan A (2011) Multicentre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 15:756-763
19. Portenoy RK, Payne D, Jacobsen P (1999) Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81:129-134 (Pubitemid 29199908)
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383 (Pubitemid 17055592)
21. Groll DL, To T, Bombardier C, Wright JG (2005) The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 58:595-602 (Pubitemid 40692725)
22. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundstrom S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S (2011) Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 152:1139-1145
23. Hjermstad MJ, Lie HC, Caraceni A, Currow DC, Fainsinger RL, Gundersen OE, Haugen DF, Heitzer E, Radbruch L, Stone PC, Strasser F, Kaasa S, Loge JH (2012) Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA. J Pain Symptom Manage 44:639-654
24. Fainsinger RL, Nekolaichuk CL (2008) A "TNM" classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer 16:547-555
25. Knudsen AK, Brunelli C, Klepstad P, Aass N, Apolone G, Corli O, MontanariM, Caraceni A, Kaasa S (2012)Which domains should be included in a cancer pain classification system? Analyses of longitudinal data. Pain 153:696-703